Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 May 24;24(1):1395.
doi: 10.1186/s12889-024-18816-z.

Epidemiologic profile of inflammatory bowel disease in Eastern Mediterranean Region (EMRO) countries: a systematic review and meta-analysis

Zahra Momayez Sanat #  1   2 , Homayoon Vahedi #  2 , Reza Malekzadeh  2 , Zeinab Fanni  3
Affiliations
Meta-Analysis

Epidemiologic profile of inflammatory bowel disease in Eastern Mediterranean Region (EMRO) countries: a systematic review and meta-analysis

Zahra Momayez Sanat et al. BMC Public Health. .

Abstract

Background: Inflammatory bowel disease (IBD) consists of two main types: Crohn's disease (CD) and ulcerative colitis (UC). The epidemiology of IBD patients has not been comprehensively studied in EMRO countries; therefore, we conducted this meta-analysis to study the epidemiology of this disease in these countries.

Methods: We searched four international databases, namely Scopus, Web of Knowledge (ISI), Medline/PubMed, and ProQuest, from inception up to the end of May 2023. The Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guideline was used to carry out this systematic review and meta-analysis investigation. Using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist, the quality of the selected papers was assessed.

Results: Based on the results of this study, the incidence of UC in EMRO countries was 2.65 per 100,000 (95% CI: 1.39-3.90), and the incidence of CD was 1.16 per 100,000 (95% CI: 0.73-1.59). The most commonly involved intestinal segment in CD was the terminal ileum (44.7%, 95% CI: 34.7-55.2), followed by the ileum (29.8%, 95% CI: 22.2-38.6), and colon (18.7%, 95% CI: 10.8-30.4). However, in UC patients, extensive colitis was the most common finding (32.3%, 95% CI: 26.4-38.8), followed by proctosigmoiditis (27.9%, 95% CI: 21.1-35.8), left-sided colitis (27.4%, 95% CI: 22.7-32.7), and proctitis (22.6%, 95% CI: 17.5-28.5).

Conclusion: As a result, we were able to establish the traits of IBD patients in EMRO nations. UC patients had a higher incidence than CD patients. The most common regions of involvement in CD and UC patients, respectively, were the colon and pancolitis. Compared to UC patients, CD patients had a higher history of appendectomy.

Keywords: Crohn’s disease; Inflammatory bowel disease; Meta-analysis; Systematic review; Ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of the included eligible studies in systematic review
Fig. 2
Fig. 2
A Incidence of UC in EMRO countries, B Incidence of UC in EMRO countries, C Prevalence of Ulcerative Colitis among men, D Prevalence of Crohn Disease among men, E Mean Age at diagnosis for Ulcerative Colitis, F Mean Age at diagnosis for Crohn Disease, G Terminal ileum involvement in CD, H Ileal involvement in CD, I Colon involvement in CD
Fig. 3
Fig. 3
A Extensive colitis involvement in UC, B Proctosigmoiditis involvement in UC, C Left sided colitis involvement in UC patients, D Proctitis involvement in UC, E Prevalence of smoking in CD patients, F Prevalence of smoking in UC patients, G Prevalence of positive family history in UC patients, H Prevalence of positive family history in CD patients, I (Upper figure): History of appendectomy in CD patients, J (Lower figure): History of appendectomy in UC patients
See this image and copyright information in PMC

References

    1. Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi: 10.1016/S0140-6736(17)32448-0. - DOI - PubMed
    1. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727. doi: 10.1038/nrgastro.2015.150. - DOI - PubMed
    1. Keivanlou MH, Amini-Salehi E, Joukar F, Letafatkar N, Habibi A, Norouzi N, et al. Family history of cancer as a potential risk factor for colorectal cancer in EMRO countries: a systematic review and meta-analysis. Sci Rep. 2023;13(1):17457. doi: 10.1038/s41598-023-44487-8. - DOI - PMC - PubMed
    1. GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17-30. 10.1016/S2468-1253(19)30333-4. Epub 2019 Oct 21. - PMC - PubMed
    1. Freeman K, Ryan R, Parsons N, Taylor-Phillips S, Willis BH, Clarke A. The incidence and prevalence of inflammatory bowel disease in UK primary care: a retrospective cohort study of the IQVIA medical research database. BMC Gastroenterol. 2021;21(1):139. doi: 10.1186/s12876-021-01716-6. - DOI - PMC - PubMed

MeSH terms